返回 Agenda
Session 7 Track 1: Paradigm Shift in Data Management and How to Enrich Business Intelligence to Benefit the Industry
Session Chair(s)
Brooke Casselberry, MS, RAC
Vice President, Advisory and Delivery, Epista Life Science, United States
This session cover case studies from three top biopharmaceutical companies and how they are changing the way they use data in their organizations. You will learn how organizations are using data and standards in more expansive ways. You will hear directly from peers on the steps taken to change the current thinking in their organizations on data, RIM, IDMP, and overall standards.
Learning Objective : Upon completion of this session, the participant should be able to:
- Learn how organizations are using data and standards in more expansive ways
- Hear directly from peers on the steps taken to change the current thinking in their organizations on data, RIM, IDMP, and overall standards
- Discuss how to change their system, data, and user interface approach from being an administrative activity to an analytical activity
Speaker(s)
Kelly Hnat
Principal, K2 Consulting/Gens & Associates, United States
Case Study – Implementing a Paradigm Shift in RIM Data Management: From Administrative Afterthought to Strategic Asset
Andrea Herrmann, PHARMD
Head of Regulatory Compliance & Regulatory Information Management, Merck Healthcare KGaa, Germany
Case Study – Improvement of Collaboration Across Industries
John Stanek
Sr. Associate, Global Regulatory Affairs, Johnson & Johnson Group of Consumer Companies, United States
Case Study – Enhanced Planning for Due Diligence and M&A Using the ISO IDMP Data Model